Literature DB >> 569503

Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell.

D T Vistica.   

Abstract

Melaphan, L-phenylalanine mustard, is transported by the L1210 cell through carriers of the leucine (L) type. Its initial rate of transport is inhibited by both L-leucine, a naturally occuring L system amino acid and 2-aminobicyclo[2,2,1]heptane-2-carboxylic acid (BCH), A SYNTHETIC AMINO ACID WHICH IS TRANSPORTED BY THE L system in the Ehrlich ascites tumor cell. Both amino acids inhibited melphalan transport comparably in sodium-free medium. However, BCH, in medium containing sodium, was unable to reduce a component of melphalan transport which was readily inhibited by leucine but not by alpha-aminoisobutyric acid. Inhibition analysis indicated that leucine competes with BCH for transport but that a portion of leucine transport is not readily inhibited by BCH. These results suggest that in the L1010 cell melphalan is transported equally by a BCH-sensitive, sodium-independent L system and a BCH-insensitive, sodium-dependent L system.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 569503     DOI: 10.1016/0005-2736(79)90217-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transport.

Authors:  V Skalski; W Feindel; L C Panasci
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

2.  Inhibition of methionine uptake by methotrexate in mouse leukemia L1210 cells.

Authors:  K J Scanlon; A R Cashmore; M Kashani-Sabet; M Pallai; R N Dreyer; B A Moroson; M Saketos
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity.

Authors:  M J Yagi; J G Bekesi; M D Daniel; J F Holland; A De Barbieri
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  Effects of amino acids on the transport and cytotoxicity of melphalan by human bone marrow cells and human tumor cells.

Authors:  M Dufour; L C Panasci; J St Germain; L Boulet
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU.

Authors:  L C Panasci; M Dufour; L Chevalier; G Isabel; P Lazarus; A McQuillan; E Arbit; S Brem; W Feindel
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Tyrosine transport in a human melanoma cell line as a basis for selective transport of cytotoxic analogues.

Authors:  J M Pankovich; K Jimbow
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

Review 7.  Fifty years of melphalan use in hematopoietic stem cell transplantation.

Authors:  Ulas D Bayraktar; Qaiser Bashir; Muzaffar Qazilbash; Richard E Champlin; Stefan O Ciurea
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-24       Impact factor: 5.742

8.  Comparison of the transport of chlorozotocin and CCNU in L1210 leukemia and murine bone marrow cells in vitro.

Authors:  P Lazarus; J S Germina; M Dufour; G Palmer; D Wallace; L C Panasci
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer.

Authors:  D C Smith; D I Jodrell; M J Egorin; R M Ambinder; E G Zuhowski; W Kreis; P G Ellis; D L Trump
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  Protein-associated intercalator-induced DNA scission is enhanced by estrogen stimulation in human breast cancer cells.

Authors:  L A Zwelling; D Kerrigan; M E Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.